National guidelines recommend that all women with ovarian cancer get tested for a BRCA mutation

BRCA mutations play an important role in treatment with LYNPARZA

You may already know about BRCA mutations. They’re changes or alterations that take place in your BRCA gene. Testing positive for a BRCA mutation helps determine if you can start LYNPARZA earlier in your treatment plan, after responding to the first line of platinum-based chemotherapy. If you test negative for a BRCA mutation, LYNPARZA may be an option for you later in your treatment plan. Ask to be tested as early as diagnosis.

There are 2 types of BRCA mutations:

Inherited Mutations

Inherited BRCA mutation*

This type of mutation is passed down from a family member. It can be found in your blood, saliva, or tumor.

Acquired Mutations

Acquired BRCA mutation

This type of mutation is not passed down—it occurs randomly. It can only be found in your tumor. Blood or saliva testing cannot find acquired BRCA mutations.

nbsp;

*There are FDA-approved tests that detect inherited and acquired BRCA mutations to determine if you are able to take LYNPARZA as a maintenance treatment after responding to the first line of platinum-based chemotherapy.

If you have either of these mutations, you may be able to start LYNPARZA earlier.

There are 2 types of tests that can determine your BRCA status

YOU CAN START THE PROCESS BY TALKING TO YOUR HEALTH CARE PROVIDER ABOUT TESTING FOR A BRCA MUTATION. YOUR HEALTH CARE PROVIDER WILL RECOMMEND WHICH OF THESE 2 TESTS IS RIGHT FOR YOU.

TUMOR TESTING

This type of test uses a tissue sample to identify BRCA mutations. It finds both inherited and acquired BRCA mutations. Acquired mutations occur randomly, meaning that they are not inherited. Only tumor testing can find an acquired BRCA mutation.

BLOOD OR SALIVA TESTING

This type of test can be done at any time. It uses a DNA sample to identify BRCA mutations. Blood or saliva testing identifies inherited BRCA mutations, which is helpful to determine your family’s risk of certain cancers.

It is possible to do both tests, so that you have as much information as possible.

Test does not distinguish between inherited and acquired mutations.

Be your own advocate and talk to your health care provider today about testing early for a BRCA mutation.

If you have a BRCA mutation, your health care provider may prescribe LYNPARZA earlier

This chart helps you navigate when your health care provider may prescribe LYNPARZA as a maintenance treatment.

AFTER 1ST LINE OF CHEMOTHERAPY

  • You’ve responded to your first line of platinum-based chemotherapy
  • You have a BRCA mutation confirmed by your health care provider

OR

AFTER 2ND LINE OF CHEMOTHERAPY

  • Your cancer has returned, and you’ve responded to your second line or later of platinum-based chemotherapy
  • You may or may not have a BRCA mutation

You’ll notice that you need to have a BRCA mutation in order to be prescribed LYNPARZA after responding to the first line of platinum-based chemotherapy, whereas after responding to the second line of platinum-based chemotherapy, you may be prescribed LYNPARZA regardless of whether or not you have a BRCA mutation.

LYNPARZA was studied in women like you—both with and without a BRCA mutation.

Ask your health care provider when you’ll be tested for a BRCA mutation. You could be tested as early as diagnosis.

Important Safety Information

WHAT IS LYNPARZA?

LYNPARZA is a prescription medicine used to treat adults who have:

  • advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. LYNPARZA is used as maintenance treatment after the cancer has responded to your first treatment with platinum-based chemotherapy. Your healthcare provider will perform a test to make sure that LYNPARZA is right for you
  • ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, as maintenance treatment, when the cancer has come back. LYNPARZA is used after the cancer has responded to treatment with platinum-based chemotherapy
  • advanced ovarian cancer with a certain type of abnormal inherited BRCA gene, and have received treatment with 3 or more prior types of chemotherapy medicines. Your healthcare provider will perform a test to make sure that LYNPARZA is right for you

It is not known if LYNPARZA is safe and effective in children.

IMPORTANT SAFETY INFORMATION

LYNPARZA may cause serious side effects, including:

Bone marrow problems called Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML). Some people who have ovarian cancer or breast cancer and who have received previous treatment with chemotherapy, radiotherapy, or certain other medicines for their cancer have developed MDS or AML during treatment with LYNPARZA. MDS or AML may lead to death. If you develop MDS or AML, your healthcare provider will stop treatment with LYNPARZA.

Symptoms of low blood cell counts are common during treatment with LYNPARZA, but can be a sign of serious bone marrow problems, including MDS or AML. Symptoms may include weakness, weight loss, fever, frequent infections, blood in urine or stool, shortness of breath, feeling very tired, bruising or bleeding more easily.

Your healthcare provider will do blood tests to check your blood cell counts:

  • before treatment with LYNPARZA
  • every month during treatment with LYNPARZA
  • weekly if you have low blood cell counts that last a long time. Your healthcare provider may stop treatment with LYNPARZA until your blood cell counts improve

Lung problems (pneumonitis). Tell your healthcare provider if you have any new or worsening symptoms of lung problems, including shortness of breath, fever, cough, or wheezing. Your healthcare provider may do a chest x-ray if you have any of these symptoms. Your healthcare provider may temporarily or completely stop treatment if you develop pneumonitis. Pneumonitis may lead to death.

Before taking LYNPARZA, tell your healthcare provider about all of your medical conditions, including if you:

  • have lung or breathing problems
  • have kidney problems
  • are pregnant, become pregnant, or plan to become pregnant. LYNPARZA can harm your unborn baby and may cause loss of pregnancy (miscarriage)
    • If you are able to become pregnant, your healthcare provider may do a pregnancy test before you start treatment with LYNPARZA
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment with LYNPARZA and for 6 months after the last dose of LYNPARZA. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if LYNPARZA passes into your breast milk. Do not breastfeed during treatment with LYNPARZA and for 1 month after receiving the last dose of LYNPARZA. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking LYNPARZA and certain other medicines may affect how LYNPARZA works and may cause side effects.

How should I take LYNPARZA?

  • Take LYNPARZA tablets exactly as your healthcare provider tells you
  • Do not change your dose or stop taking LYNPARZA unless your healthcare provider tells you to. Your healthcare provider may temporarily stop treatment with LYNPARZA or change your dose of LYNPARZA if you experience side effects
  • Your healthcare provider will decide how long you stay on treatment
  • Do not take more than 4 LYNPARZA tablets in 1 day. If you have any questions about LYNPARZA, talk to your healthcare provider or pharmacist
  • Take LYNPARZA by mouth 2 times a day
  • Each dose should be taken about 12 hours apart
  • Swallow LYNPARZA tablets whole. Do not chew, crush, dissolve, or divide the tablets
  • Take LYNPARZA with or without food
  • If you miss a dose of LYNPARZA, take your next dose at your usual scheduled time. Do not take an extra dose to make up for a missed dose
  • If you take too much LYNPARZA, call your healthcare provider or go to the nearest hospital emergency room right away

What should I avoid while taking LYNPARZA?

Avoid grapefruit, grapefruit juice, Seville oranges, and Seville orange juice during treatment with LYNPARZA since they may increase the level of LYNPARZA in your blood.

LYNPARZA may cause serious side effects. The most common side effects of LYNPARZA are:

  • nausea or vomiting. Tell your healthcare provider if you get nausea or vomiting. Your healthcare provider may prescribe medicines to treat these symptoms
  • low number of red or white blood cells
  • stomach-area (abdominal) pain
  • dizziness
  • tiredness or weakness
  • sore throat or runny nose
  • diarrhea
  • joint, muscle, and back pain
  • headache
  • constipation
  • mouth sores
  • respiratory tract infections
  • changes in kidney function blood test
  • changes in the way food tastes
  • loss of appetite
  • low number of platelets
  • indigestion or heartburn

These are not all the possible side effects of LYNPARZA. Call your healthcare provider for medical advice about side effects.

You may report side effects related to AstraZeneca products by clicking here.

Please click here for complete Prescribing Information, including Patient Information (Medication Guide).